UT-MD Anderson Cancer Center: AACR - Early Trial Results Show Benefits of FGFR Inhibitors and PARP/ATR Inhibitor Combinations in Multiple Tumor Types
April 19, 2023
April 19, 2023
HOUSTON, Texas, April 19 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on April 18, 2023:
* * *
MD Anderson researchers present targeted therapy results from two clinical trial findings
* * *
Researchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple clinical trials today at the American Association for Cancer Research (AACR) Annual Meeting 20 . . .
* * *
MD Anderson researchers present targeted therapy results from two clinical trial findings
* * *
Researchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple clinical trials today at the American Association for Cancer Research (AACR) Annual Meeting 20 . . .